VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Niacinamide
Phase 2
Small molecule
W
Washington University School of Medicine
1
Indications
7
Total Trials
1
Active Trials
0
Competitors
Clinical
Trials by Indication
[1]
Melasma
1 trial
DNA Methylation in Malar Melasma and Its Change by Sunscreen, Retinoic Acid and Niacinamide.
Completed
·
U
Universidad Autonoma de San Luis Potosí
·
Phase 1
·
NCT03392623
·
28 enrolled
Schizophrenia
1 trial
Treatment of Acute Schizophrenia With Vitamin Therapy
Completed
·
—
·
Phase 4
·
NCT00140166
·
55 enrolled
Injury
1 trial
NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial
Recruiting
·
K
Kaiser Permanente
·
Phase 2
·
NCT04750616
·
304 enrolled
Lymphoid Malignancies
1 trial
Phase I Vorinostat in Combination With Niacinamide and Etoposide for Lymphoid Malignancies
Completed
·
—
·
Phase 1
·
NCT00691210
·
40 enrolled
Peritoneal Dialysis
1 trial
The Effect of Oral Niacinamide on Plasma Phosphorus Levels in Peritoneal Dialysis Patients
Completed
·
W
Washington University School of Medicine
·
Phase 1/2
·
NCT00508885
·
17 enrolled
2 more indications
Dialysis Patients
1 trial
The Effect of Oral Niacinamide on Serum Phosphorus Levels in Hemodialysis Patients
Completed
·
W
Washington University School of Medicine
·
Phase 1
·
NCT00316472
·
40 enrolled
Hyperpigmentation
1 trial
Clinical Trial of 4% Niacinamide Versus 0.05% Desonide for the Treatment of Axillar Hyperpigmentation
Completed
·
U
Universidad Autonoma de San Luis Potosí
·
Phase 4
·
NCT01542138
·
28 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
7 trial records for Niacinamide. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Niacinamide compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Niacinamide. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Washington University School of Medicine company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Phase 2
[1]
Company
W
Washington University School of Medicine
Related News